Bio View

Bio View CapEx Growth

The Year-over-Year CapEx Growth of Bio View (BIOV.TA) as of Oct 18, 2026 is 51.43 %. In the previous year, Year-over-Year CapEx Growth was -87.23 % — a change of -158.96% (higher).

CapEx Growth

51.43 %

YoY

-158.96%

Last updated:

Year-over-Year CapEx Growth of Bio View is 2025 51.43 % . Year-over-Year CapEx Growth of Bio View was 2024 -87.23 % . It decreases by -158.96% higher compared to the previous year.

The Bio View CapEx Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx Growth
Date
CapEx Growth
Jan 1, 2018
-10.89 ILS
Jan 1, 2019
15.56 ILS
Jan 1, 2020
46.15 ILS
Jan 1, 2021
116.78 ILS
Jan 1, 2022
-30.65 ILS
Jan 1, 2023
-40.04 ILS
Jan 1, 2024
-87.23 ILS
Jan 1, 2025
51.43 ILS
The Bio View CapEx Growth history
YEARCapEx GrowthYoY
51.43 %-158.96%
-87.23 %+117.83%
-40.04 %+30.64%
-30.65 %-126.25%
116.78 %+153.02%
46.15 %+196.70%
15.56 %-242.83%
-10.89 %-115.61%
69.75 %-260.96%
-43.33 %-148.59%
89.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio View Stock analysis

What does Bio View do? Bio View Ltd, based in Rehovot, Israel, operates in the Health Care sector, specializing in the research, development, marketing, and sales of advanced imaging systems. The company manufactures and services the Duet workstation, an automated cell diagnostic system used in cytology, hematology, and pathology laboratories for detecting and analyzing abnormal cells. It also offers the ALLEGRO and ACCORD workstations for specialized applications in cancer diagnosis, minimal-residual disease monitoring, and FISH-based analyses in cytogenetics and oncology. Bio View is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio View stock

Year-over-Year CapEx Growth of Bio View is 51.43 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year CapEx Growth Bio View since 2006 – with annual values, charts, and detailed analysis.

CapEx growth measures the percentage change in capital expenditures. Increasing CapEx can signal investment in future growth capacity.

To evaluate Year-over-Year CapEx Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year CapEx Growth.

Year-over-Year CapEx Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year CapEx Growth's Bio View historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Bio View

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Bio View